Endpoints News

CEO and C-suite are out in battle for control of Aurinia

Published

2 weeks ago

on

Biotech takeover specialist Kevin Tang is consolidating control at Aurinia Pharmaceuticals, and has replaced the CEO and C-suite at the company, according to a securities filing Monday.

Tang, who serves as chairman of the board …

Related Topics:

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version